Menopausal hormone therapy is not approved for the prevention of type 2 diabetes because its risks may outweigh the benefits in many cases. But according to Franck Mauvais-Jarvis, MD, it should not be withheld from women with increased risk of type 2 diabetes who seek treatment for their menopausal symptoms. Read more